Back to Results

TetraLogic Pharmaceuticals Corp (TLOG)

TetraLogic Pharmaceuticals Corp. is a healthcare company listed on OTC Markets as common stock under the ticker TLOG. The company is a clinical-stage biopharmaceutical developer focused on small-molecule therapeutics for oncology and infectious diseases. Its pipeline includes two clinical-stage candidates: birinapant, a SMAC-mimetic designed to promote apoptosis in damaged cells, and SHAPE, a proprietary histone deacetylase inhibitor being developed as a topical treatment for early-stage cutaneous T-cell lymphoma. TetraLogic also has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to study SMAC-mimetics, including birinapant, in infectious disease applications. The company was incorporated in 2001, changed its name from Gentara Corporation in January 2006, and is headquartered in Malvern, Pennsylvania.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-TLOG
Not available
Not available
Not available
Fair
0.0%
2.431 K
Valuation • Fair Value

TetraLogic Pharmaceuticals Corp (OTC-TLOG) Fair Value by Valuation Model

No usable valuation estimate is currently available for TetraLogic Pharmaceuticals Corp (OTC-TLOG); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for TetraLogic Pharmaceuticals Corp (OTC-TLOG). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for TetraLogic Pharmaceuticals Corp (OTC-TLOG)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review TetraLogic Pharmaceuticals Corp (OTC-TLOG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TetraLogic Pharmaceuticals Corp (OTC-TLOG)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TetraLogic Pharmaceuticals Corp (OTC-TLOG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for TetraLogic Pharmaceuticals Corp (OTC-TLOG)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for TetraLogic Pharmaceuticals Corp (OTC-TLOG). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

TetraLogic Pharmaceuticals Corp (OTC-TLOG) Stock FAQ

Data-supported answers about TetraLogic Pharmaceuticals Corp (OTC-TLOG), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for TetraLogic Pharmaceuticals Corp (OTC-TLOG). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for TetraLogic Pharmaceuticals Corp (OTC-TLOG) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for TetraLogic Pharmaceuticals Corp (OTC-TLOG).

The current market capitalization listed for TetraLogic Pharmaceuticals Corp is 2.431 K.

The ticker symbol for TetraLogic Pharmaceuticals Corp is OTC-TLOG, and the stock is listed on OTC Markets.

TetraLogic Pharmaceuticals Corp (OTC-TLOG) is listed on OTC Markets.

Similar Biotechnology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABBV NYSE AbbVie Inc Fair Value Fair Market Cap 466.4 B
AMGN NASDAQ Amgen Inc Fair Value Fair Market Cap 208.5 B
GILD NASDAQ Gilead Sciences Inc Fair Value Fair Market Cap 186 B
VRTX NASDAQ Vertex Pharmaceuticals Inc Fair Value Fair Market Cap 128.8 B
REGN NASDAQ Regeneron Pharmaceuticals Inc Fair Value Undervalued Market Cap 78.353 B
ARGX NASDAQ argenx NV ADR Fair Value Fair Market Cap 62.595 B
MRNA NASDAQ Moderna Inc Fair Value Overvalued Market Cap 61.522 B
NTRA NASDAQ Natera Inc Fair Value Overvalued Market Cap 53.245 B
RVMD NASDAQ Revolution Medicines Inc Fair Value Fair Market Cap 40.928 B
ONC NASDAQ BeOne Medicines AG DRC Fair Value Fair Market Cap 39.9 B
ALNY NASDAQ Alnylam Pharmaceuticals Inc Fair Value Fair Market Cap 32.055 B
BIIB NASDAQ Biogen Inc Fair Value Fair Market Cap 31.841 B
ROIV NASDAQ Roivant Sciences Ltd Fair Value Overvalued Market Cap 28.748 B
INSM NASDAQ Insmed Inc Fair Value Fair Market Cap 26.206 B
INCY NASDAQ Incyte Corporation Fair Value Fair Market Cap 25.4 B
BNTX NASDAQ BioNTech SE Fair Value Fair Market Cap 24.131 B
UTHR NASDAQ United Therapeutics Corporation Fair Value Fair Market Cap 21.214 B
GMAB NASDAQ Genmab AS Fair Value Overvalued Market Cap 20.751 B
ASND NASDAQ Ascendis Pharma AS Fair Value Fair Market Cap 15.546 B
NBIX NASDAQ Neurocrine Biosciences Inc Fair Value Undervalued Market Cap 14.864 B